Teva Pharmaceutical Industries ADR
(TEVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 4,332,000 | 4,164,000 | 3,819,000 | 4,457,000 | 3,850,000 |
| Cost of Goods | 2,183,000 | 2,140,000 | 2,048,000 | 2,040,000 | 1,999,000 |
| Gross Profit | 2,148,000 | 2,024,000 | 1,771,000 | 2,416,000 | 1,851,000 |
| Operating Expenses | 1,598,000 | 2,030,000 | 1,988,000 | 1,662,000 | 1,506,000 |
| Operating Income | 551,000 | -6,000 | -217,000 | 755,000 | 345,000 |
| Other Income | -872,000 | -238,000 | -254,000 | -247,000 | -281,000 |
| Pre-tax Income | -321,000 | -244,000 | -471,000 | 508,000 | 64,000 |
| Income Tax | 69,000 | 630,000 | -52,000 | 40,000 | -12,000 |
| Net Income Continuous | -390,000 | -874,000 | -419,000 | 468,000 | 76,000 |
| Minority Interests | 47,000 | -29,000 | -280,000 | 4,000 | 8,000 |
| Net Income | $-437,000 | $-845,000 | $-139,000 | $463,000 | $69,000 |
| EPS Basic Total Ops | -0.39 | -0.75 | -0.12 | 0.42 | 0.06 |
| EPS Basic Continuous Ops | -0.34 | -0.77 | -0.37 | 0.42 | 0.07 |
| EPS Diluted Total Ops | -0.39 | -0.75 | -0.12 | 0.42 | 0.06 |
| EPS Diluted Continuous Ops | -0.34 | -0.77 | -0.37 | 0.42 | 0.07 |
| EPS Diluted Before Non-Recurring Items | 0.67 | 0.58 | 0.46 | N/A | N/A |
| EBITDA(a) | $810,000 | $253,000 | $55,000 | $1,021,000 | $628,000 |